Definium Therapeutics, Inc.

DFTX

Market cap$5.28 B

Rank#1386

Filings445

Definium Therapeutics, Inc. has filed 445 public company documents between 2020 and 2026. The most frequent type is insider trade (126 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchDFTX overview$5.28 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1386See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with CURLFPeer viewPut DFTX beside CURLF across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow DFTX via RSS

Similar companies to research next

CCURLFCuraleaf

RGCRegencell Bioscience Holdings Limited

CRONCronos Group Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
SCHEDULE 13G	SCHEDULE 13G	4mo ago2026-02-17	-	View filing
SCHEDULE 13G	SCHEDULE 13G	4mo ago2026-02-17	-	View filing

Definium Therapeutics, Inc.

Similar companies to research next

Year